By meta-analyzing the whole-exomes of 24,248 cases and 97,322 controls, we implicate ultra-rare coding variants (URVs) in ten genes as conferring substantial risk for schizophrenia (odds ratios 3–50, p <2.14×10−6), and 32 genes at an FDR < 5%. These genes have the greatest expression in central nervous system neurons and have diverse molecular functions that include the formation, structure, and function of the synapse. The associations of NMDA receptor subunit GRIN2A and AMPA receptor subunit GRIA3 provide support for the dysfunction of the glutamatergic system as a mechanistic hypothesis in the pathogenesis of schizophrenia. We find statistically-significant evidence for an overlap of rare variant risk between schizophrenia, autism spectrum disorders (ASD), and severe neurodevelopmental disorders (DD/ID), supporting a neurodevelopmental etiology for schizophrenia. We show that protein-truncating variants in GRIN2A, TRIO, and CACNA1G confer risk for schizophrenia whereas specific missense mutations in these genes confer risk for DD/ID. Nevertheless, few of the strongly associated schizophrenia genes appear to confer risk for DD/ID. We demonstrate that genes prioritized from common variant analyses of schizophrenia are enriched in rare variant risk, suggesting that common and rare genetic risk factors at least partially converge on the same underlying pathogenic biological processes. Even after excluding statistically-significantly associated genes, schizophrenia cases still carry a substantial excess of URVs, implying that more schizophrenia risk genes await discovery using this approach.
Figure 6: The contributions of ultra-rare PTVs [protein-truncating variants] to schizophrenia risk. A: Genetic architecture of schizophrenia. statistically-significant genetic associations for schizophrenia from the most recent GWAS, CNV, and sequencing studies are displayed. The in-sample odds ratio is plotted against the minor allele frequency in the general population. The color of each dot corresponds to the source of the association, and the size of the dot to the odds ratio. The shaded area represented the LOESS-smoothed lines of the upper and lower bounds of the point estimates…Because schizophrenia as a trait is under strong selection38–40, we expect that URVs of large effect to be frequently de novo or of very recent origin and contribute to risk in only a fraction of diagnosed patients.
![Figure 6: The contributions of ultra-rare PTVs [protein-truncating variants] to schizophrenia risk. A: Genetic architecture of schizophrenia. statistically-significant genetic associations for schizophrenia from the most recent GWAS, CNV, and sequencing studies are displayed. The in-sample odds ratio is plotted against the minor allele frequency in the general population. The color of each dot corresponds to the source of the association, and the size of the dot to the odds ratio. The shaded area represented the LOESS-smoothed lines of the upper and lower bounds of the point estimates…Because schizophrenia as a trait is under strong selection38–40, we expect that URVs of large effect to be frequently <em>de novo</em> or of very recent origin and contribute to risk in only a fraction of diagnosed patients.](/doc/genetics/heritable/rare/2020-singh-figure6a-thecontributionsofultrarareptvstoschizophreniarisk.jpg)